Ameliorate Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -34.14%
- Profit Growth 82.30%
- Ebitda 3.60%
- Net Worth -2.72%
- Total Assets 23.25%
About Ameliorate Pharmacare
Ameliorate Pharmacare Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 June 2011 and has a history of 13 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pratap Chandra and Ria Sindhwani serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100KA2011PTC059048
-
Company No.
059048
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ameliorate Pharmacare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ria Sindhwani
|
Director | 31-Jan-2022 | Current |
|
Pratap Chandra
|
Director | 30-Nov-2021 | Current |
Financial Performance of Ameliorate Pharmacare.
Ameliorate Pharmacare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 34.14% decrease. The company also saw a substantial improvement in profitability, with a 82.3% increase in profit. The company's net worth dipped by a decrease of 2.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ameliorate Pharmacare?
In 2021, Ameliorate Pharmacare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Prednalytics Health Private LimitedPratap Chandra is a mutual person
-
New Ramdev Health And Wellness Private LimitedPratap Chandra and Ria Sindhwani are mutual person
-
Digifra Technology Private Limited
Pratap Chandra is a mutual person
-
Reddot Life Private Limited
Pratap Chandra is a mutual person
-
House Meds Private Limited
Ria Sindhwani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ameliorate Pharmacare?
Ameliorate Pharmacare has a workforce of 37 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ameliorate Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ameliorate Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
